The precision of your advisor's number alone should warrant some caution. I think it's at about fair value, give or take a few % points.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025